NewsCentre

Showing 11 to 20 of 30 results
Breakthrough in battling Triple-Negative Breast Cancer
CityU biologists discover super-enhancers that switch on Triple-Negative Breast Cancer genes.
CityU wins 12 awards at Inventions Geneva Evaluation Days, the highest number among all universities in Hong Kong
Researchers from CityU won the highest number of awards among all universities in Hong Kong at IGED 2021, including a Gold Medal with Congratulations of the Jury, five Gold Medals, three Silver Medals and three Bronze Medals, demonstrating the excellence of the research carried out at CityU.
 Targeted genetic analysis helps dissect disease inheritance
An international research team co-led by CityU has developed a high-throughput biological assay technique that provides valuable data for finding type-2 diabetes key biomarkers for diagnostics and treatment.
ITF funding secured for anti-Covid-19 research
Research at CityU aimed at tackling Covid-19 has attracted over $7.1 million in funding from the Innovation and Technology Fund (ITF) under the Innovation and Technology Commission.
Uncovering the secret of RNA paves the way for drug discovery for Covid-19
A research team led by scientists at CityU has developed a new method for identifying binding proteins of non-coding RNAs in living cells, which can be applied in cancer diagnosis and stem cell research, and may even help to identify potential antiviral drug targets to combat Covid-19.
cancer immunotherapy
Unleashing the intrinsic power of the immune system to fight cancer is the focus of an award-winning research led by a biomedical scientist and her research team at CityU.
CityU’s new blood test technology for accurate detection of cancer cells
Groundbreaking technology that can accurately perform early screening for cancer cells and effectively monitor disease status has been successfully developed by a biomedical research team at CityU.
World-first coating developed at CityU
A world-first self-healable anti-smudge coating successfully developed by a research team at CityU could lead to production costs that are 80% lower than for existing materials.
New brain studies for treating myelin-related diseases
A study by CityU reveals for the first time that schema-like learning can foster the growth and regeneration of brain myelin, thereby enhancing the synchrony of neural networks.
First dual stem cell therapy for cardiac repair
A research team featuring an expert from CityU has developed the first dual stem therapy which gives hope for a new treatment for repairing myocardial infarction heart.

Contact Information

Communications and Institutional Research Office

Back to top